- Home
- SVRE vs TNON Comparison
SVRE vs TNON Comparison
Compare SVRE & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- TNON
- Stock Information
- Founded
- SVRE 2014
- TNON 2012
- Country
- SVRE Israel
- TNON United States
- Employees
- SVRE N/A
- TNON N/A
- Industry
- SVRE
- TNON Medical Specialities
- Sector
- SVRE
- TNON Health Care
- Exchange
- SVRE Nasdaq
- TNON Nasdaq
- Market Cap
- SVRE 4.1M
- TNON 4.8M
- IPO Year
- SVRE 2022
- TNON 2022
- Fundamental
- Price
- SVRE $4.11
- TNON $1.39
- Analyst Decision
- SVRE
- TNON Strong Buy
- Analyst Count
- SVRE 0
- TNON 2
- Target Price
- SVRE N/A
- TNON $16.00
- AVG Volume (30 Days)
- SVRE 69.5K
- TNON 95.9K
- Earning Date
- SVRE 03-24-2025
- TNON 03-11-2025
- Dividend Yield
- SVRE N/A
- TNON N/A
- EPS Growth
- SVRE N/A
- TNON N/A
- EPS
- SVRE N/A
- TNON N/A
- Revenue
- SVRE $458,952.00
- TNON $3,315,000.00
- Revenue This Year
- SVRE N/A
- TNON $29.03
- Revenue Next Year
- SVRE $422.52
- TNON $100.29
- P/E Ratio
- SVRE N/A
- TNON N/A
- Revenue Growth
- SVRE N/A
- TNON 38.30
- 52 Week Low
- SVRE $3.84
- TNON $1.35
- 52 Week High
- SVRE $359.95
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- SVRE 26.43
- TNON 32.21
- Support Level
- SVRE $5.07
- TNON $1.35
- Resistance Level
- SVRE $7.33
- TNON $1.59
- Average True Range (ATR)
- SVRE 1.11
- TNON 0.11
- MACD
- SVRE 0.02
- TNON 0.01
- Stochastic Oscillator
- SVRE 5.81
- TNON 14.81
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.